Critical role of peroxisome proliferator-activated receptor γ on anoikis and invasion of squamous cell carcinoma

Clinical Cancer Research

Volumn 11, Issue 11, 2005, Pages 4012-4021

  Masuda, Tomotake ^a   Wada, Koichiro ^a   Nakajima, Atsushi ^b   Okura, Masaya ^a   Kudo, Chiho ^a   Kadowaki, Takashi ^c   Kogo, Mikihiko ^a   Kamisaki, Yoshinori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2 CHLORO 5 NITROBENZANILIDE; ALPHA5 INTEGRIN; FIBRONECTIN; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANOIKIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADULT; AGED; ANILIDES; ANOIKIS; BENZAMIDES; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PPAR GAMMA; PROTEIN-TYROSINE KINASES; PYRIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 20344391690     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0087     Document Type: Article

References (34)

1. Prince S, Bailey BM. Squamous carcinoma of the tongue: review. Br J Oral Maxillofac Surg 1999;37:164-74.
2. Goepfert H. Squamous cell carcinoma of the head and neck: past progress and future promise. CA Cancer J Clin 1998;48:195-8.
3. Okura M, Hiranuma T, Adachi T, et al. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution. Cancer 1998;82:804-15.
4. Leon X, Quer M, Orus C, et al. Distant metastases in head and neck cancer patients who achieved locoregional control. Head Neck 2000;22:680-6.
5. Wedman J, Balm AJ, Hart AA, et al. Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck 1996;18:311-6.
6. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-88.
7. Panigrahy D, Shen LQ, Kieran MW. et al. Therapeutic potential of thiazolidinediones as anticancer agents. Expert Opin Investig Drugs 2003;12:1925-37.
8. Martelli ML, Iuliano R, LePera I, et al. Inhibitory effects of peroxisome poliferatoractivated receptor γ on thyroid carcinoma cell growth. J Clin Endocrinol Metab 2002;87:4728-35.
9. Lefebvre AM, Chen I, Desreumaux P, et al. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCmin/+ mice. Nat Med 1998;4: 1053-7.
10. Saez E, Tontonoz P, Nelson MC, et al. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat Med 1998;4:1058-61.
11. Sarraf P, Mueller E, Jones D, et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 1998;4:1046-52.
12. Schaefer KL, Wada K, Takahashi H, et al. PPARγ inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells. Cancer Res 2005;65:2251-9.
13. Urade M, Ogura T, Mima T, et al. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer 1992;69:2589-97.
14. Okumura K, Konishi A, Tanaka M, et al. Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS. J Cancer Res Clin Oncol 1996;122:243-8.
15. Ikuta M, Podyma KA, Maruyama K, et al. Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol 2001;37:177-84.
16. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 2004;5:104-12.
17. Shimada T, Kojima K, Yoshiura K, et al. Characteristics of the peroxisome proliferator-activated receptor γ ligand-induced apoptosis in colon cancer cells. Gut 2002;50:563-7.
18. Eibl G, Wente MN, Reber HA, Nines OJ. Peroxisome proliferator-activated receptor γ induces pancreatic cell apoptosis. Biochem Biophys Res Commun 2001; 287:522-9.
19. Ohta K, Endo T, Haraguchi K, et al. Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 2001; 86:2170-7.
20. Frish SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26.
21. Chen HC, Appeddu PA, Parsons JT, et al. Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 1995;270:16995-9.
22. Sieg DJ, Hauck CR, Ilic D, et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000;2:249-56.
23. Zhang Z, Vuori K, Reed JC, et al. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A 1995;92:6161-5.
24. Giancotti FG, Ruoslahti E. Integrin signalling. Science 1999;285:1028-32.
25. Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 2002;97:336-43.
26. Nikitakis NG, Siavash H, Hebert C, et al. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes down-regulation of Stat3 in human oral SCCa cells. Br J Cancer 2002;87:1396-403.
27. 2 but not by troglitazone. J Dent Res 2003;82:802-6.
28. Yoshida K, Hirose Y, Tanaka T, et al. Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor γ ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci 2003;94: 365-71.
29. Owens LV, Xu L, Dent GA, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996;3:100-5.
30. Yamada KM, Geiger B. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 1997;9:76-85.
31. Gardner OS, Shiau CW, Chen CS, et al. PPARγ-independent activation of p38 MARK by thiazolidine-diones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress. J Biol Chem 2005; 280:10109-18.
32. Wei L, Yang Y, Yu Q. Tyrosine kinase-dependent phosphatidylinositol 3′ -kinase, and mitogen-activated protein kinase-independent signalling pathway prevent lung adenocarcinoma cells from anoikis. Cancer Res 2001;6:2439-44.
33. Sincock PM, Mayrhofer G, Ashman LK. Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and α5β1 integrin. J Histochem Cytochem 1997;45:515-25.
34. Fitter S, Sincock PM, Jolliffe CN, et al. Transmembrane 4 superfamily protein CD151 (PETA-3) associates with β1 and αIIbβ3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J 1999;338:61-70.